List view / Grid view
Drug delivery refers to approaches for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect.
26 January 2016 | By Victoria White
Scientists from UTSW have crafted synthetic "dendrimer" nanoparticles that are able to provide a tumour-suppressing effect without further damaging the liver or neighbouring tissue...
12 January 2016 | By Victoria White
The first four investments of the newly focused initiative include $46 million in financing to companies at early stages of the discovery process that are actively exploring Conditionally Active Biologics (CABs), immuno-oncology, neurodegenerative technologies and gene therapy...
12 January 2016 | By Victoria White
A new study describes the design of a CAR architecture with an integrated switch-on system that permits control over CAR T-cell functions...
8 January 2016 | By Victoria White
The partnership will focus on the delivery of recombinant Glial Cell Line-Derived Neurotrophic Factor to affected brain regions by way of implanted, encapsulated cell therapy devices...
5 January 2016 | By Victoria White
Renova and Research Development Foundation (RDF) have entered into a worldwide exclusive license agreement for RDF's portfolio of urocortin and stresscopin genes, as well as select peptides and proteins...
3 December 2015 | By Victoria White
Researchers say nanobombs might overcome a biological barrier that has blocked development of agents that work by altering the expression of genes in cancer cells...
The success story of Mapp Pharmaceuticals’ experimental drug, ZMapp, during last year’s Ebola outbreak highlights the potential of plant-made monoclonal antibodies (mAbs) as life-saving treatments.
20 November 2015 | By Victoria White
The technology has already been successfully tested in the laboratory. If it works in patients, the therapy could one day revolutionise treatment for many forms of cancer...
18 November 2015 | By Victoria White
DBV Tecnologies observed an immunogenic response in mice and swine treated with Viaskin with a patented formulation containing an N-FsII antigen...
11 November 2015 | By Victoria White
Preclinical studies confirm the efficacy of Anisina when delivered using a clinically relevant formulation, mode of administration and dosing regimen...
5 November 2015 | By Victoria White
Researchers have shown that the microbe S. islandicus, normally found in hot and acidic volcanic springs, is capable of delivering drugs to the human body...
3 November 2015 | By Victoria White
The collaboration will leverage the scientific expertise of the two organisations to discover and develop up to five cancer immunotherapies...
27 October 2015 | By Victoria White
Testing the system with lung cancer cells, the researchers showed that the ligand-guided protein cages selectively penetrated and killed more than 70% of the cancer cells...
22 October 2015 | By Victoria White
Medlab will apply its nanotechnology delivery system to an existing statin compound, atorvastatin, for patients suffering high levels of cholesterol...
12 October 2015 | By Victoria White
Lilly has announced plans to add 30,000 square feet to its research and development site at the Alexandria Centre for Life Science in New York...
